{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-079340","form_type":"8-K","ticker":"VYGR","cik":"0001640266","company_name":"Voyager Therapeutics, Inc.","filed_at":"2023-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.650103+00:00","generated_at":"2026-06-13T10:35:54.542976+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Voyager Therapeutics appoints Jacquelyn Fahey Sandell as Chief Legal Officer","bullets":["Jacquelyn Fahey Sandell named CLO effective July 10, 2023; reports to CEO Alfred Sandrock.","Base salary of $450,000 per year; eligible for annual cash bonus at 40% of base salary target.","Inducement equity grant: option to purchase 122,000 shares (4-year vest) and RSU for 61,000 shares (3-year vest).","Severance includes 12 months base salary, pro-rata target bonus, COBRA subsidy, and full equity acceleration upon qualifying termination within 12 months of a sale event."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-079340","json":"https://secwatch.observer/filing/0001104659-23-079340.json","markdown":"https://secwatch.observer/filing/0001104659-23-079340.md","text":"https://secwatch.observer/filing/0001104659-23-079340.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000110465923079340/0001104659-23-079340-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000110465923079340/tm2320812d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T10:35:54.542976+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}